[{"address1": "One World Trade Center", "address2": "Suite 8500", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "212-220-6633", "website": "https://www.mindmed.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.", "fullTimeEmployees": 57, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Barrow", "age": 34, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 931133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel Rollings Karlin M.A., M.D.", "age": 43, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 658522, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miriam Halperin Wernli B.A., M.A., M.B.A., MBA, Ph.D.", "age": 70, "title": "Executive President", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 552464, "exercisedValue": 0, "unexercisedValue": 1030416}, {"maxAge": 1, "name": "Dr. Scott M. Freeman M.D.", "age": 66, "title": "Co-Founder & Clinical Advisor", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 319730, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leonard  Latchman", "title": "Co-founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carrie F. Liao CPA, CGMA", "age": 57, "title": "VP & Chief Accounting Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark R. Sullivan J.D.", "age": 52, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francois P. Lilienthal M.B.A., M.D.", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stephanie  Fagan", "title": "Chief Corporate Affairs Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gregg  Pratt Ph.D.", "title": "Chief Regulatory & Quality Assurance Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 7, "governanceEpochDate": 1733011200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 7.015, "open": 6.96, "dayLow": 6.9225, "dayHigh": 7.355, "regularMarketPreviousClose": 7.015, "regularMarketOpen": 6.96, "regularMarketDayLow": 6.9225, "regularMarketDayHigh": 7.355, "beta": 2.332, "forwardPE": -4.7507195, "volume": 1420559, "regularMarketVolume": 1420559, "averageVolume": 1179243, "averageVolume10days": 1197520, "averageDailyVolume10Day": 1197520, "bid": 7.11, "ask": 7.21, "bidSize": 300, "askSize": 300, "marketCap": 525054944, "fiftyTwoWeekLow": 3.49, "fiftyTwoWeekHigh": 12.22, "fiftyDayAverage": 7.0919, "twoHundredDayAverage": 7.669625, "currency": "USD", "enterpriseValue": 254081904, "floatShares": 59342203, "sharesOutstanding": 73331696, "sharesShort": 9707406, "sharesShortPriorMonth": 9983900, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.13239999, "heldPercentInsiders": 0.0114400005, "heldPercentInstitutions": 0.68184, "shortRatio": 5.4, "shortPercentOfFloat": 0.1325, "impliedSharesOutstanding": 73331696, "bookValue": 3.214, "priceToBook": 2.2277536, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -97802000, "trailingEps": -1.71, "forwardEps": -1.37, "lastSplitFactor": "1:15", "lastSplitDate": 1661731200, "52WeekChange": 0.85012925, "SandP52WeekChange": 0.2421279, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "MNMD", "underlyingSymbol": "MNMD", "shortName": "Mind Medicine (MindMed) Inc.", "longName": "Mind Medicine (MindMed) Inc.", "firstTradeDateEpochUtc": 1479220200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "82effaa6-cea3-362e-b9a1-33a692529ba0", "messageBoardId": "finmb_631045282", "gmtOffSetMilliseconds": -18000000, "currentPrice": 7.16, "targetHighPrice": 55.0, "targetLowPrice": 16.0, "targetMeanPrice": 25.88889, "targetMedianPrice": 20.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 295284000, "totalCashPerShare": 4.027, "totalDebt": 24311000, "quickRatio": 8.877, "currentRatio": 8.999, "debtToEquity": 9.272, "returnOnAssets": -0.25378, "returnOnEquity": -0.54612, "freeCashflow": -40368124, "operatingCashflow": -74341000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-21"}]